Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population-Reference-Cited by-同舟云学术

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population

Published:2021-03-26 Issue:4 Volume:7 Page:375-384
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Zhao Ruiying¹^ORCID,Yao Feng²,Xiang Chan¹,Zhao Jikai¹^ORCID,Shang Zhanxian¹,Guo Lianying¹,Ding Wenjie¹,Ma Shengji¹,Yu Anbo¹,Shao Jinchen¹,Zhu Lei¹,Han Yuchen¹

Affiliation:

1. Department of Pathology, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai PR China

2. Department of Thoracic Surgery, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai PR China

Funder

Health and Family Planning Commission of Sichuan Province

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.208

Reference28 articles.

1. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

2. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

3. Molecular characterization of cancers with NTRK gene fusions

4. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

5. Efficacy of Larotrectinib inTRKFusion–Positive Cancers in Adults and Children

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors;npj Precision Oncology;2024-09-11

2. Feasibility of two-step approach for screening NTRK fusion in two major subtypes of non-small cell lung cancer within a large cohort;Human Pathology;2024-07

3. Poor outcome in congenital mesoblastic nephroma with TPM3::NTRK1 fusion: a case report from multi-disciplinary treatment to molecular tumor board;Translational Pediatrics;2024-06

4. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan;Cancer Medicine;2024-06

5. EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation;Targeted Oncology;2024-02-28